Some studies reported that anti-NKG2D antibodies can delay NK cell-mediated allergic airway inflammation, block CD4+T cell-mediated colitis, improve collagen-induced arthritis, and alleviate NKT cell-mediated acute hepatitis30–33. This evidence concerns the gene KLRK1 and colitis.